COLORADO – June 2025 – June marks Cancer Immunotherapy Awareness Month, a dedicated time to increase understanding of this innovative approach that harnesses the body's own immune system to fight cancer. Rocky Mountain Cancer Centers (RMCC) observes this important month by highlighting the profound impact immunotherapy has on the lives of cancer patients and survivors. 

For cancer patients and survivors, Cancer Immunotherapy Awareness Month is crucial as immunotherapy offers new hope and treatment options, sometimes providing long-lasting responses even when other therapies have been exhausted. Understanding immunotherapy empowers patients to engage more knowledgeably in discussions with their oncology teams about potential treatment pathways and the latest advancements.

"Immunotherapy represents a paradigm shift in how we approach cancer treatment, offering a beacon of hope for many patients," said Dr. Manojkumar Bupathi, medical oncologist and RMCC practice president. "It's truly inspiring to see the remarkable responses some patients experience as their own immune system is unleashed against their cancer. This month, we want to empower patients with knowledge, so they feel confident discussing these cutting-edge options with their care team."

Physician oncology experts at RMCC possess in-depth knowledge of the complexities of cancer immunotherapy, including various types like checkpoint inhibitors and CAR T-cell therapy. Leveraging their expertise, RMCC physicians carefully evaluate each patient's unique cancer profile to determine if immunotherapy is a suitable and potentially effective treatment option.

"The power of immunotherapy lies in its ability to offer highly personalized and often durable responses," commented Dr. Alonso Pacheco, medical oncologist and RMCC medical director. "For our patients, this means not only the potential for extended survival but also a significantly improved quality of life. At RMCC, we are committed to integrating the latest immunotherapy advancements into our treatment strategies, ensuring our patients have access to the most promising therapies available."

RMCC's commitment to staying at the forefront of cancer research means their physician oncologists are skilled in administering and managing the nuances of immunotherapy, ultimately striving to improve outcomes and quality of life for their patients. RMCC plays a significant role in this endeavor through its affiliation with the Sarah Cannon Research Institute (SCRI), one of the world's leading oncology research organizations. This affiliation provides RMCC patients with access to groundbreaking clinical trials and the latest advancements in cancer care, including novel immunotherapy approaches.

Rocky Mountain Cancer Centers encourages everyone to learn more about cancer immunotherapy and its potential to transform cancer care. For more information about immunotherapy options available at RMCC, please visit rockymountaincancercenters.com/cancer-treatments/immunotherapy. 

RMCC is part of The U.S. Oncology Network, a highly respected national organization collaborating to advance innovative care and deliver optimal outcomes. As Colorado’s leader in cancer treatment, we’ve been delivering world-class cancer care with compassion and expertise for more than 30 years, and we make our patients’ lives easier by offering coordinated care access in 19 locations throughout Colorado. So, if you find yourself facing new challenges in your health journey, we’ll be on your side, empowering Your Courage with Our Proven Experience.

# # #

Rocky Mountain Cancer Centers (RMCC) is an independent, physician-led practice that delivers leading-edge technology and treatment options and conducts innovative research. For more than 30 years, RMCC has pioneered community-based care to enable more cancer patients to receive high-quality treatment while staying close to the support of family and friends.

Rocky Mountain Cancer Centers treats more adult cancer than any other healthcare organization in Colorado, providing 19 locations and a network of 54 physicians specializing in cancer care throughout the state. RMCC is collectively focused on treating cancer and blood disorders with advanced technology and innovative research no matter where you live, while taking a community-based approach of integrated subspecialty oncology care. This enables patients to access leading-edge treatment while living at home and receiving the critical support of family and friends.

Patients who are treated at RMCC can participate in some of the most promising national clinical trials for a broad range of cancers. RMCC has played a role in the development of more than 100 FDA-approved cancer-fighting drugs – about one-third of cancer therapies approved by the FDA to date. At any given time, more than 150 national clinical trials are open throughout The Network.

Media Contacts
RMCC Media
RMCCmedia@usoncology.com